DiaSorin S.p.A. (OTCMKTS:DSRLF) Sees Significant Decline in Short Interest

DiaSorin S.p.A. (OTCMKTS:DSRLFGet Free Report) was the recipient of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 35,100 shares, a decrease of 8.6% from the November 15th total of 38,400 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

DiaSorin Trading Down 0.3 %

Shares of OTCMKTS:DSRLF opened at $106.85 on Wednesday. The stock has a 50 day moving average of $104.87 and a 200 day moving average of $102.91. DiaSorin has a 12-month low of $105.88 and a 12-month high of $108.79.

Analysts Set New Price Targets

Separately, UBS Group cut shares of DiaSorin from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 26th.

Get Our Latest Stock Analysis on DSRLF

DiaSorin Company Profile

(Get Free Report)

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.

Featured Articles

Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.